Difficulty: Medium
Average Score: 65%
Practice
Patients with ITP have an increased risk of bleeding. What would you expect careful monitoring of?
Correct answer
A
Rationale
In patients with Immune Thrombocytopenic Purpura (ITP), there is a decreased platelet count, leading to an increased risk of bleeding. Therefore, careful monitoring of platelet count is crucial in managing these patients. Option A, "Platelet count and RBC," is the correct answer because monitoring platelet count provides information on the patient's risk of bleeding and guides treatment decisions.
Option B, "WBC and bleeding time," is incorrect because ITP primarily affects platelets, not white blood cells or clotting time. Monitoring WBC is not directly relevant to bleeding risks in ITP. Bleeding time is a less reliable test and is not routinely used for monitoring ITP.
Option C, "PT and PTT," is incorrect because these tests assess the extrinsic and intrinsic pathways of the coagulation cascade, which are not directly impacted in ITP. Monitoring PT and PTT is more relevant in assessing coagulation abnormalities in conditions like hemophilia or liver disease.
Option D, "Iron and ferritin levels," is also incorrect because these tests assess iron stores in the body and are not directly related to the risk of bleeding in ITP. Monitoring iron and ferritin levels is more indicative of iron deficiency anemia rather than bleeding risks in ITP.
Educationally, understanding the rationale behind monitoring specific parameters in different hematologic conditions is essential for providing optimal patient care. In ITP, focusing on platelet count monitoring helps in assessing bleeding risks, guiding treatment strategies, and evaluating the effectiveness of interventions like platelet transfusions or medications. This knowledge is crucial for healthcare professionals managing patients with hematologic disorders to ensure appropriate and evidence-based care.
Option B, "WBC and bleeding time," is incorrect because ITP primarily affects platelets, not white blood cells or clotting time. Monitoring WBC is not directly relevant to bleeding risks in ITP. Bleeding time is a less reliable test and is not routinely used for monitoring ITP.
Option C, "PT and PTT," is incorrect because these tests assess the extrinsic and intrinsic pathways of the coagulation cascade, which are not directly impacted in ITP. Monitoring PT and PTT is more relevant in assessing coagulation abnormalities in conditions like hemophilia or liver disease.
Option D, "Iron and ferritin levels," is also incorrect because these tests assess iron stores in the body and are not directly related to the risk of bleeding in ITP. Monitoring iron and ferritin levels is more indicative of iron deficiency anemia rather than bleeding risks in ITP.
Educationally, understanding the rationale behind monitoring specific parameters in different hematologic conditions is essential for providing optimal patient care. In ITP, focusing on platelet count monitoring helps in assessing bleeding risks, guiding treatment strategies, and evaluating the effectiveness of interventions like platelet transfusions or medications. This knowledge is crucial for healthcare professionals managing patients with hematologic disorders to ensure appropriate and evidence-based care.